Table 1. Demographic Table.
| Main demographics | AR(n = 54) | no-AR(n = 56) | pIFTA (n = 12) |
|---|---|---|---|
| Recipient gender (F, %) | 20 (37) | 25 (45) | 5 (42) |
| Recipient age (years) | 9.5±4.7 | 10.7±5.4 | 11.4±5.7 |
| Donor gender (F, %) | 26 (47) | 20 (35) | 6 (50) |
| Donor age (years) | 27.9±13.6 | 30.0 ±11.5 | 33.5±6.8 |
| Recipient Race (% Caucasion/Asian/Hispanic/African-American) | 60/20/15/5 | 58/20/20/2 | 55/18/19/2 |
| Type of Transplant (%)-Living | 9 (17.3) | 6 (10.5) | 1 (8.3) |
| Type of Transplant (%)-Living-related | 2 (3.8) | 10 (17.5) | 4(33.3) |
| Type of Transplant (%)-cadaver | 7 (13.4) | 19 (33.3) | 2 (16.7) |
| *Cause of ESRD (%) (1/2/3/4/5/6) | 10/5/8/9/6/16 | 14/5/5/8/8/16 | 2/0/3/2/2/3 |
| Serum Creatinine (mg/dL) (mean+/- SD) | 1.45±0.88 | 1.50±0.79 | 0.97± 0.0 |
| post-transplantation (month) | 33.99±31.58 | 14.00±9.15 | 11.32±9.91 |
*ESRD (1/2/3/4/5/6): 1, glomerulonephritis, 2, polycystic kidney disease, 3, renal dysplasia, 4, reflux nephropathy, 5, obstructive uropathy, 6 = other or unknown. None of these selected patients had delayed graft function. 20% of AR episodes were associated with documentation of non-adherence with medications (self-reported), appointments and/or laboratory measurements. Though the time post-transplant was significantly greater for AR (p<0.05); there was no difference in post-transplant time between no-AR and pIFTA.